| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |